Trial Profile
The effect of exenatide on body weight, energy expenditure and hunger in obese women without diabetes mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 24 Feb 2012 Actual end date (September 2010) added as reported by ClinicalTrials.gov.
- 24 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 31 Oct 2011 Results published in the Diabetes Care.